Schedule I in the U.S.Serious cardiac riskNot FDA-approvedNo dosing or referrals

Claim extract · Listening Library

Hubbard / Third Wave: Ibogaine Initiative as policy media

LAST REVIEWED 2026-09-22 · MEDIA CLAIM EXTRACT · HIGH-CONFIDENCE LL

High-confidence Listening Library policy-advocacy row (Third Wave Ep. 305, W. Bryan Hubbard). Kentucky proposal history and multi-state research-funding narrative — not federal descheduling and not clinical proof.

Listening Library source (outbound)

third-wave-305-bryan-hubbard — Third Wave episode page. Confidence: high. Primary URL verified HTTP 200 (2026-09-22 PT).

Testable claims (media → desk)

  1. Claim: State research-funding initiatives equal a change in federal Schedule I status.
    Desk: Schedule I vs state bills FAQ — state appropriations ≠ CSA rescheduling.
  2. Claim: Advocacy momentum implies an FDA-approved ibogaine pathway already exists.
    Desk: FDA approval FAQ · study permission ≠ approval.
  3. Claim: Policy storytelling proves clinical efficacy for OUD/PTSD/TBI.
    Desk: OUD · PTSD · TBI · registered trials.
  4. Related media: Cross-check Perry / Hubbard policy media and primary bill texts on the policy hub.

Verdict

Useful policy-history media; funding politics are not Schedule I repeal, FDA approval, or efficacy proof.

Continue reading

Policy hub · Perry / Hubbard · Trials · Listening Library